2021 ISPE Aseptic Conference

Setting the Pace for 30 Years!

Mark your calendar for the 30th Anniversary of the ISPE Aseptic Conference being held on 15–17 March 2021.

The ISPE Aseptic Conference has been setting the pace for the evolution of sterile manufacturing processes and technologies in the pharmaceutical industry for 30 years. The virtual conference platform will provide a unique opportunity for expanded global participation, both by speakers and attendees. This close-knit community of aseptic professionals has an ongoing commitment to quality and innovation. We know you do to, so please join us to celebrate the tradition and be a part of the next-generation transformation.


What to Expect

Join The Discussion

2021 ISPE Aseptic Conference Quick Facts

Featured Speakers


Conference Highlights


Conference Topics:

  • COVID-19 Impact 
  • Aseptic Process Safety 
  • Modular Robotic Fill/Finish Lines
  • Annex 1 Revisions for Barrier Technologies 
  • Why, When, and What Regulatory Agencies Expect
  • Facility Considerations for Next Gen Sterile Manufacturing
  • Containment & Cross Contamination Control for Bio Safety
  • Single Use: Why all the hype? Is it really worth it?
  • H2O2: Implications for Process & Qualification 
  • Intersection of ATMPs & New Technologies
  • Devices and Decontamination 

Why Attend Virtually

  • Feel like You're In-Person with a Fully Interactive Digital Experience
    Our event portal is easy to navigate and will allow you to view presentations, access PDFs of the presentations, take downloadable notes in each session, participate in polls, chat with other attendees, and participate in LIVE Q&A sessions with speakers.
    alt 1
  • Build Your Experience
    Add the sessions you want to attend with the click of a button to build your own custom agenda.
    alt 2
  • Gain Actionable Insights
    Global experts will be at your fingertips sharing their knowledge and lessons learned on advanced therapeutic medicinal products (ATMPs) including cell and gene therapies, digitalization, single-use technology, implications of ICH Q12 for biopharma, and much more.
    alt 3

Virtual Event FAQs


Who Should Attend

  • Aseptic manufacturing professionals and management
  • Aseptic processing consultants and global regulatory inspectors
  • Compounding pharmacy and small-scale facilities professionals
  • Design, facilities, building, commissioning, validation professionals
  • Engineering system owners or project managers responsible for aseptic processing equipment
  • Equipment manufacturers and suppliers providing state-of-the-art aseptic technology including robotics
  • Industrial Hygienist for operational safety in aseptic processing
  • Plant managers
  • Professional new to aseptic processing operations
  • Professionals new to Aseptic processing and product protection
  • Project managers
  • Quality Assurance personnel responsible for cleaning and prevention of cross contamination
  • Quality Assurance personnel responsible for maintaining the integrity of aseptic systems
  • Quality Systems/Assurance and Quality Control (QA/QC) including microbiology professionals
  • Research &Development professionals
  • Sterile Products Processing Community of Practice
  • Supply chain managers
  • Validation personnel responsible for aseptic processing equipment qualification

Media Partner


Recieve Notifications

Stay up-to-date on registration, education opportunities, speakers, hotel discounts, exhibitor information, and more by signing up to receive notifications for the 2021 ISPE Aseptic Conference.

Name
Company Type

Program Committee

Jörg Zimmermann
Vice President, Vetter Development Service, External Affairs
Vetter Pharma-Fertigung GmbH & Co.
Chair
David Doleski
Compliance Head for Biologics Quality Operations
Sanofi
Co-Chair
Richard Denk
Senior Consultant Aseptic Processing & Containment
SKAN AG
Dina Manfredi
Director of Sales and Business Development
GMP Systems Inc
Christa B. Myers
Pharmaceutical Market Director
CRB
Klaus Ullherr
Senior Product Manager
Syntegon Technology GmbH
Keith W. Weseli, CPIP
Director of Operations, Midwest Region
CAI
Eric S. Thostesen
Senior Director Regulatory Compliance
Johnson & Johnson
Michael G. Higgins
Senior Compliance Advisor
Roche/Genentech